BIT.AX - Biotron Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 544.08M
Enterprise value 338.34M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)41.09
Price/book (mrq)8.22
Enterprise value/revenue 335.74
Enterprise value/EBITDA 6-22.71

Trading information

Stock price history

Beta (3Y monthly) -8.74
52-week change 3-71.54%
S&P500 52-week change 36.81%
52-week high 30.4450
52-week low 30.0550
50-day moving average 30.0738
200-day moving average 30.0779

Share statistics

Avg vol (3-month) 33.67M
Avg vol (10-day) 31.43M
Shares outstanding 5595.71M
Float 480.65M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 21/1
Last split date 327 Mar 2006

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)30 Jun 2019


Profit margin -150.24%
Operating margin (ttm)-158.55%

Management effectiveness

Return on assets (ttm)-28.44%
Return on equity (ttm)-47.97%

Income statement

Revenue (ttm)1.07M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)1.07M
Net income avi to common (ttm)-1.61M
Diluted EPS (ttm)-0.0030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.74M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)14.02
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-1.5M
Levered free cash flow (ttm)-995.82k